Exact Mass: 323.1481

Exact Mass Matches: 323.1481

Found 153 metabolites which its exact mass value is equals to given mass value 323.1481, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Galipine

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

C20H21NO3 (323.1521)


   

Rucaparib

Rucaparib

C19H18FN3O (323.1434)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

Naftifine hydrochloride

Naftifine hydrochloride

C21H22ClN (323.1441)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Histidyltryptophyldiketopiperazine

Histidyltryptophyldiketopiperazine

C17H17N5O2 (323.1382)


   

Cyproheptadine hydrochloride

Cyproheptadine hydrochloride

C21H22ClN (323.1441)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine hydrochloride is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders[1][2].

   

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaene

C20H21NO3 (323.1521)


Mukonicine is found in herbs and spices. Mukonicine is an alkaloid from the leaves of Murraya koenigii (curry leaf tree

   

Koenigicine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


Koenigicine is found in herbs and spices. Koenigicine is an alkaloid from the leaves of Murraya koenigii (curryleaf tree

   

N-Monodemethylolopatadine

2-[(2Z)-2-[3-(methylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid

C20H21NO3 (323.1521)


N-Monodemethylolopatadine is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)

   

7-[(2-Benzyl-3-sulfanylpropanoyl)amino]heptanoic acid

7-[(2-Benzyl-1-hydroxy-3-sulphanylpropylidene)amino]heptanoic acid

C17H25NO3S (323.1555)


   

Cyamemazine

10-[3-(dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile

C19H21N3S (323.1456)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].

   

Renzapride

4-Amino-N-{1-azabicyclo[3.3.1]nonan-4-yl}-5-chloro-2-methoxybenzene-1-carboximidate

C16H22ClN3O2 (323.14)


   

Rubraca

6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13)-tetraen-9-one

C19H18FN3O (323.1434)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   
   

12E-Dechloroisorumbrin

12E-Dechloroisorumbrin

C20H21NO3 (323.1521)


   
   

UNII-88O0DY329T

UNII-88O0DY329T

C20H21NO3 (323.1521)


   

N-Acetylnornuciferine

N-Acetylnornuciferine

C20H21NO3 (323.1521)


   
   

Axinisothiocyanate H

Axinisothiocyanate H

C17H25NO3S (323.1555)


   

O-Methylglycocitrine-II

O-Methylglycocitrine-II

C20H21NO3 (323.1521)


   

Cyamemazine

Cyamemazine

C19H21N3S (323.1456)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].

   

5HPP-33

2-(2,6-Diisopropylphenyl)-5-hydroxyisoindoline-1,3-dione

C20H21NO3 (323.1521)


CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5213 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5223 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5314; ORIGINAL_PRECURSOR_SCAN_NO 5312 ORIGINAL_ACQUISITION_NO 5234; CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9749; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9783; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9807; ORIGINAL_PRECURSOR_SCAN_NO 9805 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9830; ORIGINAL_PRECURSOR_SCAN_NO 9826 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9801; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9831; ORIGINAL_PRECURSOR_SCAN_NO 9828

   

Dimefline HCL

Dimefline HCL

C20H21NO3 (323.1521)


R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   
   

TEB_M324a

TEB_M324a

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2501

   

TEB_M324b *

TEB_M324b *

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2504

   

TEB_M324c

TEB_M324c

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2505

   

Oprea1_325596

Oprea1_325596

C20H21NO3 (323.1521)


   
   

(+)-(S)-N-propionylcaaverine

(+)-(S)-N-propionylcaaverine

C20H21NO3 (323.1521)


   
   
   

3-O-methylglycocitrine-II|O3-Me-Glycocitrine II

3-O-methylglycocitrine-II|O3-Me-Glycocitrine II

C20H21NO3 (323.1521)


   

1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one

1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one

C20H21NO3 (323.1521)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

SCHEMBL10716722

SCHEMBL10716722

C15H21N3O5 (323.1481)


   

Naftifine HCl

Naftifine HCl

C21H22ClN (323.1441)


   

C17H17N5O2_3-(1H-Imidazol-4-ylmethyl)-6-(1H-indol-3-ylmethyl)-2,5-piperazinedione

NCGC00385408-01_C17H17N5O2_3-(1H-Imidazol-4-ylmethyl)-6-(1H-indol-3-ylmethyl)-2,5-piperazinedione

C17H17N5O2 (323.1382)


   
   
   
   
   
   

3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)

3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)

C20H21NO3 (323.1521)


   

Kenidine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


   

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


   

2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine

2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine

C19H21N3S (323.1456)


   

1-CBZ-2-BENZYLPIPERIDIN-4-ONE

1-CBZ-2-BENZYLPIPERIDIN-4-ONE

C20H21NO3 (323.1521)


   

Metiapine

Metiapine

C19H21N3S (323.1456)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate

tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)


   

1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate

tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)


   

Mepixanox

Mepixanox

C20H21NO3 (323.1521)


R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

BOC--(4-FLUORBENZYL)-DL-PRO-OH

BOC--(4-FLUORBENZYL)-DL-PRO-OH

C17H22FNO4 (323.1533)


   

boc-(r)-alpha-(4-fluorobenzyl)-proline

boc-(r)-alpha-(4-fluorobenzyl)-proline

C17H22FNO4 (323.1533)


   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-fluorobenzyl)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-fluorobenzyl)pyrrolidine-2-carboxylic acid

C17H22FNO4 (323.1533)


   

Renzapride

Renzapride

C16H22ClN3O2 (323.14)


Renzapride (BRL 24924), a substituted benzamide, is a full 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride (BRL 24924) is also a 5HT2b and 5HT3 receptor antagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2].

   

(2S)-2-phenyl-2-[[(1S)-1-[4-(trifluoromethyl)phenyl]propyl]amino]ethanol

(2S)-2-phenyl-2-[[(1S)-1-[4-(trifluoromethyl)phenyl]propyl]amino]ethanol

C18H20F3NO (323.1497)


   

boc-(s)-alpha-(4-fluorobenzyl)-proline

boc-(s)-alpha-(4-fluorobenzyl)-proline

C17H22FNO4 (323.1533)


   

H-Ala-Tyr-Ala-OH

(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoic Acid

C15H21N3O5 (323.1481)


   

N-(3-HYDROXY-4,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-YL)-4-METHYL-BENZENESULFONAMIDE

N-(3-HYDROXY-4,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-YL)-4-METHYL-BENZENESULFONAMIDE

C17H25NO3S (323.1555)


   
   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

Fmoc-Prolinol

Fmoc-Prolinol

C20H21NO3 (323.1521)


   

(4-(4-Aminoquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone

(4-(4-Aminoquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone

C17H17N5O2 (323.1382)


   

TERT-BUTYL 6-(BENZYLOXY)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 6-(BENZYLOXY)-1H-INDOLE-1-CARBOXYLATE

C20H21NO3 (323.1521)


   

N-FMOC-4-PIPERIDINOL

N-FMOC-4-PIPERIDINOL

C20H21NO3 (323.1521)


   

2-fluoro-4-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]benzoic acid

2-fluoro-4-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]benzoic acid

C17H22FNO4 (323.1533)


   

(9H-FLUOREN-9-YL)METHYL 3-HYDROXYPIPERIDINE-1-CARBOXYLATE

(9H-FLUOREN-9-YL)METHYL 3-HYDROXYPIPERIDINE-1-CARBOXYLATE

C20H21NO3 (323.1521)


   

Disperse Orange 25

Disperse Orange 25

C17H17N5O2 (323.1382)


   

N-Desmethyl Olopatadine

N-Desmethyl Olopatadine

C20H21NO3 (323.1521)


   

9H-fluoren-9-ylmethyl (3R)-3-hydroxypiperidine-1-carboxylate

9H-fluoren-9-ylmethyl (3R)-3-hydroxypiperidine-1-carboxylate

C20H21NO3 (323.1521)


   

9H-fluoren-9-ylmethyl (3S)-3-hydroxypiperidine-1-carboxylate

9H-fluoren-9-ylmethyl (3S)-3-hydroxypiperidine-1-carboxylate

C20H21NO3 (323.1521)


   

Methyl (1R,2R)-2-[(4-amino-4-biphenylyl)carbonyl]cyclopentanecar boxylate

Methyl (1R,2R)-2-[(4-amino-4-biphenylyl)carbonyl]cyclopentanecar boxylate

C20H21NO3 (323.1521)


   

Mycophenolic acid D3

Mycophenolic acid D3

C17H17D3O6 (323.1448)


   

3-(4-(Trifluoromethyl)phenoxy)-N,N-dimethyl-3-phenylpropan-1-amine

3-(4-(Trifluoromethyl)phenoxy)-N,N-dimethyl-3-phenylpropan-1-amine

C18H20F3NO (323.1497)


   

11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine

11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine

C19H21N3S (323.1456)


   

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

C16H22ClN3O2 (323.14)


   

1-Benzoyl-4-benzylpiperidine-4-carboxylic acid

1-Benzoyl-4-benzylpiperidine-4-carboxylic acid

C20H21NO3 (323.1521)


   

tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate

tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate

C20H21NO3 (323.1521)


   

4-(4-methylphenyl)-2,2:6,2-terpyridine

4-(4-methylphenyl)-2,2:6,2-terpyridine

C22H17N3 (323.1422)


   

4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine

4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine

C16H23BClNO3 (323.1459)


   

N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

C14H21N5O2S (323.1416)


D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

C16H22ClN3O2 (323.14)


   

H-Ala-ala-tyr-OH

H-Ala-ala-tyr-OH

C15H21N3O5 (323.1481)


   

[1-(5-Hydroxypentyl)indol-3-yl]-(4-hydroxyphenyl)methanone

[1-(5-Hydroxypentyl)indol-3-yl]-(4-hydroxyphenyl)methanone

C20H21NO3 (323.1521)


   

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

C16H22ClN3O2 (323.14)


   

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

C16H22ClN3O2 (323.14)


   

Renzaprida

Renzaprida

C16H22ClN3O2 (323.14)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

C15H21N3O5 (323.1481)


   
   

10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

C20H21NO3 (323.1521)


   

1-[(1,2-Dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea

1-[(1,2-Dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea

C19H21N3S (323.1456)


   
   
   

8-(Diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one

8-(Diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one

C20H21NO3 (323.1521)


   
   
   
   
   
   
   
   
   
   
   

beta-D-Tyvp-(1->3)-beta-D-GalpN-OMe

beta-D-Tyvp-(1->3)-beta-D-GalpN-OMe

C13H25NO8 (323.158)


   

2-Phenylamino-4,6-diphenylpyrimidine

2-Phenylamino-4,6-diphenylpyrimidine

C22H17N3 (323.1422)


   

5-(Diethoxymethyl)-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline

5-(Diethoxymethyl)-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline

C13H26NO6P (323.1498)


   

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

C20H21NO3 (323.1521)


   
   
   
   

(S)-Renzapride

(S)-Renzapride

C16H22ClN3O2 (323.14)


(S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study[1][2].

   

1-{5-hydroxy-2,8,8-trimethyl-9h,10h,11h-phenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

1-{5-hydroxy-2,8,8-trimethyl-9h,10h,11h-phenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

C20H21NO3 (323.1521)


   

(2-{9-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

(2-{9-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

C20H21NO3 (323.1521)


   

n-[1-(4,5-dihydroxy-6-methyloxan-2-yl)-2-hydroxypyrimidin-4-ylidene]-3-methylbut-2-enamide

n-[1-(4,5-dihydroxy-6-methyloxan-2-yl)-2-hydroxypyrimidin-4-ylidene]-3-methylbut-2-enamide

C15H21N3O5 (323.1481)


   

n-[4-(benzoyloxy)butyl]-3-phenylprop-2-enimidic acid

n-[4-(benzoyloxy)butyl]-3-phenylprop-2-enimidic acid

C20H21NO3 (323.1521)


   

8,10-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

8,10-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C20H21NO3 (323.1521)


   

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]propan-1-one

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]propan-1-one

C20H21NO3 (323.1521)


   

4-methoxy-3-methyl-6-[9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

4-methoxy-3-methyl-6-[9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

C20H21NO3 (323.1521)


   

(1s,4s,4ar,7r)-7-hydroxy-1-isopropyl-4-isothiocyanato-4,7-dimethyl-3,4a,5,6-tetrahydro-2h-naphthalene-1-carboxylic acid

(1s,4s,4ar,7r)-7-hydroxy-1-isopropyl-4-isothiocyanato-4,7-dimethyl-3,4a,5,6-tetrahydro-2h-naphthalene-1-carboxylic acid

C17H25NO3S (323.1555)


   

(2s,6r)-2-methoxy-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),3,8,10-tetraen-12-ol

(2s,6r)-2-methoxy-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),3,8,10-tetraen-12-ol

C20H21NO3 (323.1521)


   

7-methoxy-4-(5-phenylpentyl)-1h-indole-2,3-dione

7-methoxy-4-(5-phenylpentyl)-1h-indole-2,3-dione

C20H21NO3 (323.1521)


   

1-[(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

1-[(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

C20H21NO3 (323.1521)


   

(2-{10-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

(2-{10-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

C20H21NO3 (323.1521)


   

(2e)-n-{4-[(e)-benzoyloxy]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(e)-benzoyloxy]butyl}-3-phenylprop-2-enimidic acid

C20H21NO3 (323.1521)


   

8,9-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

8,9-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C20H21NO3 (323.1521)


   

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

C20H21NO3 (323.1521)


   

1-[(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

1-[(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

C20H21NO3 (323.1521)


   

methyl 1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carboxylate

methyl 1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carboxylate

C20H21NO3 (323.1521)


   

4-methoxy-3-methyl-6-[(2e,4e,6e,8e)-9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

4-methoxy-3-methyl-6-[(2e,4e,6e,8e)-9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

C20H21NO3 (323.1521)


   

(12r)-17-methoxy-11,18-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12r)-17-methoxy-11,18-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C20H21NO3 (323.1521)


   

n-{1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbut-2-enamide

n-{1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbut-2-enamide

C15H21N3O5 (323.1481)


   

1-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl}ethanone

1-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl}ethanone

C20H21NO3 (323.1521)


   

1-hydroxy-3-methoxy-10-methyl-4-(3-methylbut-2-en-1-yl)acridin-9-one

1-hydroxy-3-methoxy-10-methyl-4-(3-methylbut-2-en-1-yl)acridin-9-one

C20H21NO3 (323.1521)


   

1-hydroxy-3-methoxy-10-methyl-2-(3-methylbut-2-en-1-yl)acridin-9-one

1-hydroxy-3-methoxy-10-methyl-2-(3-methylbut-2-en-1-yl)acridin-9-one

C20H21NO3 (323.1521)